News 22 mai 2024 CUTISS secures 25 million Swiss francs from investors CUTISS has closed a first Series C financing round in the amount of 25 million Swiss francs. With this, the life sciences company with a focus on...
Success stories 23 avr 2024 How BeiGene drives global cancer treatment access From its European headquarters in Basel, Switzerland, BeiGene strategically collaborates with stakeholders worldwide to advance oncology research...
News 30 jan 2024 Top Stories from Western Switzerland (January 2024) From groundbreaking advancements in agrifood and robotics to strategic economic reforms and pioneering research in space and medicine, discover W...
News 11 déc 2023 Five startups advance to final phase of DayOne Health 4.0 Five international healthcare startups – including the Bern-based startup machineMD – have made it to the final phase of DayOne Health 4.0. With ...
News 17 jan 2024 Spiden makes a breakthrough in non-invasive glucose measurements Spiden has made significant progress in the area of non-invasive glucose measurements. The company hopes to develop a wearable device on the basi...
News 26 oct 2022 Chinese vaccine manufacturer CanSino Biologics sets up shop in Geneva to launch its inhaled Covid vaccine This first inhaled Covid vaccine against was approved by Chinese authorities a month ago. This technology has the potential to protect against ot...
News 26 mai 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 08 sep 2022 Sitem Startup Club medtech machineMD raises CHF 3.2 million Bernese start-up machineMD has raised CHF 3.2 million for its medical device for the early diagnosis of neurological disorders including brain tu...
News 13 nov 2023 Bern’s journey to becoming a world-class medtech hub by 2030 The canton of Bern is on a mission to become a leading global medical hub by 2030. By combining an exceptional medical expertise medical expertis...
News 06 nov 2023 Abionic and Lascco partner with Fapon for sepsis diagnosis in China Biopôle companies Abionic and Lascco team up with Fapon to harness a groundbreaking biomarker for sepsis detection, enhancing early diagnosis cap...
News 25 oct 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
News 01 nov 2023 Bacthera’s Visp plant aims to revolutionize microbiome-based treatments In Visp, Bacthera’s MC4a Center of Excellence readies to manufacture transformative microbiome therapies, notably the Seres Therapteutics’ life-s...
News 30 sep 2021 Basel Area becomes the Swiss hotspot for Chinese pharma companies More and more Chinese pharmaceutical companies are choosing the Basel Area as location for their subsidiary in Switzerland. Among them is Hengrui...
News 14 aoû 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
News 21 aoû 2023 Top innovations out of Neuchâtel’s CSEM With a wide array of projects spanning diverse sectors, from aerospace to arts, CSEM has solidified its position as a leader in pioneering R&D en...
Fact Sheet 25 aoû 2023 China – Hainan Boao Lecheng a unique opportunity for Swiss healthcare companies to enter the Chinese market and to discover new business potential Hainan Boao Lecheng international medical tourism pilot zone, also known as "Boao Hope City", is considered a key achievement of Hainan free trad...
Industry Report 13 sep 2021 How to enter the Chinese market as a Swiss medtech company The medtech market in China has become much more challenging for foreign companies in recent years and months. The objective of this study is to ...
News 12 juil 2021 L2F’s machine learning platform raises CHF 3.7 million Vaud-based start-up L2F just raised CHF 3.7 million for its first product, Giotto Compliance, which leverages proprietary Natural Language Proces...